Watch Ticker

Prothena Corporation plc Ordinary Shares

Go to Prothena Corporation plc Ordinary Shares Website

$7.11

0.17 (2.45%)

Live

Previous Close

$6.94

Day Range

$6.73 - $7.54

Previous Day Range

$6.7 - $6.99

Market Cap

$366.6 million USD

Day Vol.

1.1 million

Previous Day Vol.

957884

Currency

USD

Primary Exchange

Nasdaq

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm

Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of Prothena Corporation PLC. Shareholders may be entitled to damages and corporate governance reforms.

Related tickers: PRTA.

Read Full Article

Delveinsight - Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight

The article discusses the growing pipeline of alpha-synuclein inhibitors, a class of investigational therapies targeting the aggregation of alpha-synuclein, a protein implicated in neurodegenerative diseases. The pipeline includes over 20 active players and 22+ pipeline therapies, with several promising candidates in various stages of clinical trials.

Related tickers: ANVS, ATHE, DNLI, HLBAY, ABBV, AZN, PRTA, RHHBY, PMN.

Read Full Article

Trending Tickers

Please sign in to view